High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

References

• Nienhuis RLF, Mandema E, Smids C. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis 1964;23:302–5.
   PubMed Web of Science ®Google Scholar
• Young BJJ, Mallya RK, Leslie RD, Clark CJM, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979;2:97 —9.
   Google Scholar
• Girbal E, Sebbag M, Gomès-Daudrix V, Simon M, Vincent C, Serre G. Characterisation of the rat oesophagus epithelium antigens defined by the so-called `antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis 1993;52:749— 57.
   Google Scholar
• Simon M, Girbal E, Sebbag M, Gomès-Daudrix V, Vincent C, Salama G, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called `antikeratin antibodies', autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387–93.
   Google Scholar
• Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E, Durieux J-J, et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672–9.
   Google Scholar
• Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux J-J, Cantagrel A, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diag-nostic test for rheumatoid arthritis. J Rheumatol 1998;25: 838 —46.
   Google Scholar
• Vincent C, de Keyser F, Masson-Bessière C, Sebbag M, Veys EM, Serre G. Anti-perinuclear factor compared with the so called `antikeratin' antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58:42 — 8.
   Google Scholar
• Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115: 294— 302.
   PubMed Web of Science ®Google Scholar
• Aho K, Palosuo T, Lukka M, Kurki P, Isomäki H, Kautiainen H, et al. Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol 1999;28:113— 6.
   Google Scholar
• Masson-Bessière C, Sebbag M, Durieux J-J, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119: 544— 52.
   Google Scholar
• Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheuma-toid arthritis-specific autoantibodies. J Clin Invest 1998;101: 273 — 81.
   PubMed Web of Science ®Google Scholar
• Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)fi-laggrin by deimination of arginine residues. J Immunol 1999; 162:585— 94.
   Google Scholar
• Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155–63.
   PubMed Web of Science ®Google Scholar
• Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournié B, Cantagrel A, et al. Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2001;60:882–7.
   Google Scholar
• Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoanti-bodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236–43.
   Google Scholar
• Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089–93.
   Google Scholar
• Bas S, Perneger TV, Seitz M, Tiercy J-M, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 2002;41:809–14.
   Google Scholar
• Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29:2074–6.
   Google Scholar
• Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letoumeur O, et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46:2051–8.
   Google Scholar
• Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969–75.
   PubMed Web of Science ®Google Scholar
• Manicourt DH, Fujimoto N, Obata K, Thonar EJ-MA. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum 1995;38: 1031–9.
   Google Scholar
• Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, et al. Circulating levels of matrix metallo-proteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol 1999;26: 251–8.
   Google Scholar
• So A, Chamot AM, Péclat V, Gerster J-C. Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status. Rheumatology (Oxford) 1999;38: 407–10.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Kanno T, Kawada A, Yamanouchi J, Yosida-Noro C, Yoshiki A, Shiraiwa M, et al. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. J Invest Dermatol 2000;115:813–23.
   Google Scholar
• Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561–77.
   PubMed Web of Science ®Google Scholar
• Vossenaar ER, van Venrooij WJ, Pruijn GJM. Anti-CCP antibodies in (early) rheumatoid arthritis. In: Conrad K, Fritzler M, Meurer M, Sack U, Shoenfeld Y, eds. Proteomics to molecular epidemiology: relevance of autoantibodies. Lengerich: Pabst Science Publishers, 2002:454–62.
   Google Scholar
• Zucker S, Mian N, Drews M, Conner C, Davidson A, Miller F, et al. Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity. J Rheumatol 1999;26:78–80.
   PubMed Web of Science ®Google Scholar
• Reparon-Schuijt CC, van Esch WJE, van Kooten C, Schellekens GA, de Jong BAW, van Venrooij WJ, et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001; 44:41–7.
   PubMed Web of Science ®Google Scholar
• Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin auto-antibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177–84.
   Google Scholar
• Lapointe E, Déry U, Vaillancourt F, Ménard HA, Senshu T. Rheumatoid sera potentially recognize all citrullinated pro-teins. Arthritis Rheum 1999;42 Suppl:586.
   Google Scholar